X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1053) 1053
Book Chapter (27) 27
Newspaper Article (12) 12
Newsletter (8) 8
Book / eBook (2) 2
Book Review (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (875) 875
male (513) 513
female (448) 448
middle aged (406) 406
oncology (406) 406
adult (389) 389
lymphomas (346) 346
index medicus (335) 335
antineoplastic combined chemotherapy protocols - therapeutic use (334) 334
aged (329) 329
hematology (283) 283
chemotherapy (252) 252
prognosis (250) 250
non-hodgkins-lymphoma (219) 219
lymphoma (201) 201
cancer (180) 180
treatment outcome (180) 180
cyclophosphamide - administration & dosage (170) 170
doxorubicin - administration & dosage (158) 158
lymphoma, non-hodgkin - drug therapy (157) 157
pathology (154) 154
vincristine - administration & dosage (152) 152
adolescent (148) 148
medicine & public health (135) 135
non-hodgkin's lymphomas (130) 130
prednisone - administration & dosage (129) 129
lymphoma, large b-cell, diffuse - drug therapy (126) 126
antineoplastic combined chemotherapy protocols - administration & dosage (113) 113
aged, 80 and over (109) 109
care and treatment (109) 109
b-cell lymphoma (106) 106
lymphoma, large b-cell, diffuse - pathology (104) 104
combined modality therapy (99) 99
non-hodgkin's lymphoma (99) 99
disease-free survival (97) 97
neoplasm staging (97) 97
survival analysis (95) 95
diagnosis (93) 93
retrospective studies (93) 93
risk factors (92) 92
epstein-barr-virus (91) 91
survival (91) 91
rituximab (88) 88
disease (83) 83
lymphoma, non-hodgkin - pathology (83) 83
survival rate (83) 83
immunohistochemistry (81) 81
remission induction (80) 80
therapy (80) 80
classification (77) 77
tumors (75) 75
lymphoma, large-cell, immunoblastic - drug therapy (74) 74
lymphoma - pathology (72) 72
diagnosis, differential (70) 70
antineoplastic combined chemotherapy protocols - adverse effects (69) 69
cyclophosphamide - therapeutic use (69) 69
transplantation (69) 69
follow-up studies (67) 67
prednisone - therapeutic use (67) 67
research (67) 67
vincristine - therapeutic use (67) 67
health aspects (65) 65
lymphoma, b-cell - drug therapy (65) 65
leukemia (64) 64
expression (63) 63
hemic and lymphatic diseases (63) 63
lymphoma, non-hodgkin - mortality (63) 63
antineoplastic agents - therapeutic use (62) 62
malignant-lymphoma (62) 62
methotrexate - administration & dosage (62) 62
doxorubicin - therapeutic use (61) 61
radiotherapy (61) 61
recurrence (61) 61
aids (59) 59
animals (59) 59
biopsy (59) 59
child (59) 59
cyclophosphamide (59) 59
hiv (59) 59
bleomycin - administration & dosage (58) 58
lymphoma - drug therapy (58) 58
lymphoma, b-cell - pathology (58) 58
diffuse large b-cell lymphoma (57) 57
etoposide - administration & dosage (56) 56
large-cell lymphoma (52) 52
t cells (51) 51
t-cell lymphoma (50) 50
lymphocytes (49) 49
immunophenotyping (48) 48
lymphoma, large b-cell, diffuse - mortality (48) 48
medicine, general & internal (48) 48
cyclophosphamide - adverse effects (47) 47
epstein-barr virus (47) 47
lymphoma, aids-related - drug therapy (47) 47
lymphoma, non-hodgkin - therapy (46) 46
patients (46) 46
combination chemotherapy (45) 45
vincristine - adverse effects (45) 45
doxorubicin (44) 44
lymphoproliferative disorders (44) 44
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1081) 1081
Spanish (8) 8
French (7) 7
Japanese (6) 6
Chinese (2) 2
German (2) 2
Danish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 1528-0020, 2010, Volume 116, Issue 23, pp. 4916 - 4925
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 3, pp. 742 - 749
...) days -6 through -4, and cyclophosphamide 60 mg/kg/d days -3 and -2. intravenous clonazepam 2 mg/d was given prophylactically from the day before initiation of busulfan therapy to the day after completion of busulfan therapy... 
THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | MODALITY | METHOTREXATE | PROTOCOL | MALIGNANCIES | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | RADIATION | NERVOUS-SYSTEM LYMPHOMA | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Thiotepa - administration & dosage | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Eye Neoplasms - therapy | Lymphoma, Large-Cell, Immunoblastic - therapy | Busulfan - administration & dosage | Feasibility Studies | Dose-Response Relationship, Drug | Eye Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Neoplasm Recurrence, Local - therapy | Central Nervous System Neoplasms - therapy | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Disease-Free Survival | Lymphoma, T-Cell - drug therapy | Lymphoma, Non-Hodgkin - therapy | Lymphoma, T-Cell - therapy | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Nervous System Diseases - chemically induced | Central Nervous System Neoplasms - drug therapy
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2012, Volume 118, Issue 16, pp. 3977 - 3983
... (HIV) infection. Despite a decrease in the incidence of HIV‐associated NHL since the advent of combination antiretroviral therapy (cART), NHL remains... 
lymphoma, non‐Hodgkin | antineoplastic agents | drug therapy | Burkitt lymphoma | human immunodeficiency virus | lymphoma, large‐cell, immunoblastic | murine‐derived monoclonal antibodies | lymphoma, acquired immunodeficiency syndrome‐related | B‐cell lymphoma | acquired immunodeficiency syndrome | immunoblastic | non-Hodgkin | large-cell | lymphoma | murine-derived monoclonal antibodies | acquired immunodeficiency syndrome-related | B-cell lymphoma | CYCLOPHOSPHAMIDE | DOXORUBICIN | DOSE-ADJUSTED EPOCH | HUMAN-IMMUNODEFICIENCY-VIRUS | PHASE-II TRIAL | ETOPOSIDE | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | ERA | ACTIVE ANTIRETROVIRAL THERAPY | Doxorubicin - therapeutic use | Lymphoma, AIDS-Related - drug therapy | Prednisone - adverse effects | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Rituximab | Male | Treatment Outcome | Clinical Trials as Topic | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Disease-Free Survival | Lymphoma, AIDS-Related - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Adult | Female | Doxorubicin - adverse effects | Prednisone - therapeutic use | Lymphoma, Non-Hodgkin - drug therapy | Care and treatment | Chemotherapy | Usage | AIDS (Disease) | Lymphomas | Drug therapy | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/1997, Volume 89, Issue 7, pp. 2291 - 2297
...), and B-large cell anaplastic (Ki-1(+)) (now termed anaplastic large cell [CD30(+)], [B-ALC]). The clinical prognostic relevance of this distinction was evaluated in a randomized prospective treatment trial... 
MULTICENTER TRIAL | BONE-MARROW TRANSPLANTATION | NEOPLASMS | DISEASE | NON-HODGKINS-LYMPHOMA | GRADE | POLYMERASE CHAIN-REACTION | PROPOSAL | STANDARD REGIMEN CHOP | HEMATOLOGY | CHEMOTHERAPY | Procarbazine - administration & dosage | Multivariate Analysis | Cyclophosphamide - administration & dosage | Prognosis | Prospective Studies | Age Factors | Lymphoma, Large-Cell, Anaplastic - radiotherapy | Humans | Middle Aged | Lymphoma, Large-Cell, Immunoblastic - mortality | Male | Life Tables | Lymphoma, Large-Cell, Immunoblastic - radiotherapy | Vincristine - administration & dosage | Adult | Female | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Lymphoma, Large-Cell, Anaplastic - mortality | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - classification | Lymphoma, Large-Cell, Anaplastic - drug therapy | Adolescent | Survival Analysis | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Aged
Journal Article
Haematologica, ISSN 0390-6078, 01/2007, Volume 92, Issue 1, pp. e11 - 12
1 Clinical Haematology/Bone Marrow Transplant Department, The Alfred, Melbourne, Victoria, Australia 2 Ronald Sawers Haemophilia Centre and Thrombosis Clinic,... 
Chromosomes, Human, Pair 8 - genetics | Translocation, Genetic | Cyclophosphamide - administration & dosage | Lymphoma, AIDS-Related - therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gingival Neoplasms - complications | Humans | Lymphoma, AIDS-Related - pathology | Male | Transplantation, Autologous | Genes, myc | Lymphoma, Large-Cell, Immunoblastic - therapy | Gingival Neoplasms - pathology | Fatal Outcome | Vincristine - administration & dosage | Adult | Radiotherapy, Adjuvant | Chromosomes, Human, Pair 8 - ultrastructure | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large-Cell, Immunoblastic - complications | Combined Modality Therapy | Lymphoma, AIDS-Related - genetics | Hemophilia A - therapy | Acquired Immunodeficiency Syndrome - drug therapy | Hemophilia A - complications | Antiretroviral Therapy, Highly Active | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gingival Neoplasms - genetics | Lymphoma, AIDS-Related - complications | Lymphoma, Large-Cell, Immunoblastic - genetics | Epstein-Barr Virus Infections - complications | Chromosomes, Human, Pair 14 - ultrastructure | Acquired Immunodeficiency Syndrome - complications | Gingival Neoplasms - therapy | Lymphoma, Large-Cell, Immunoblastic - pathology | Peripheral Blood Stem Cell Transplantation | Chromosomes, Human, Pair 14 - genetics | Immunoglobulin Heavy Chains - genetics | HEMATOLOGY
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2015, Volume 90, Issue 7, pp. 665 - 673
... large‐cell lymphoma and lymphomatoid papulosis) have a prolonged natural history. The aggressive PTCLs are associated with a short survival and are the topic... 
POSITRON-EMISSION-TOMOGRAPHY | COMPLETE REMISSION | PROGNOSTIC-FACTORS | NATURAL-KILLER-CELL | NON-HODGKINS-LYMPHOMAS | ANGIOIMMUNOBLASTIC LYMPHADENOPATHY | EUROPEAN GROUP | T/NK LYMPHOMAS | HEMATOLOGY | CLINICOPATHOLOGICAL ENTITY | WORKING PARTY | Leukemia, Large Granular Lymphocytic - diagnostic imaging | Prognosis | Humans | Enteropathy-Associated T-Cell Lymphoma - diagnostic imaging | Lymphoma, Large-Cell, Anaplastic - diagnostic imaging | Male | Risk | Positron-Emission Tomography | Lymphoma, T-Cell, Peripheral - diagnostic imaging | Immunoblastic Lymphadenopathy - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Enteropathy-Associated T-Cell Lymphoma - diagnosis | Adult | Female | Immunoblastic Lymphadenopathy - pathology | Leukemia, Large Granular Lymphocytic - pathology | Child | Radiation, Ionizing | Lymphoma, Large-Cell, Anaplastic - therapy | Enteropathy-Associated T-Cell Lymphoma - pathology | Antineoplastic Combined Chemotherapy Protocols | Immunoblastic Lymphadenopathy - diagnostic imaging | Leukemia, Large Granular Lymphocytic - diagnosis | Radiography | Immunoblastic Lymphadenopathy - therapy | Lymphoma, T-Cell, Peripheral - diagnosis | Lymphoma, T-Cell, Peripheral - pathology | Aged | Lymphoma, Large-Cell, Anaplastic - pathology | Lymphoma, T-Cell, Peripheral - therapy | Enteropathy-Associated T-Cell Lymphoma - therapy | Neoplasm Staging | Leukemia, Large Granular Lymphocytic - therapy | T cells | Non-Hodgkin's lymphomas
Journal Article
Pathology International, ISSN 1320-5463, 11/2012, Volume 62, Issue 11, pp. 763 - 770
Journal Article
Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 12, pp. 1802 - 1808
Summary A small fraction of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma develop Epstein-Barr virus–positive B-cell... 
Pathology | Fludarabine | Richter's syndrome | Immunodeficiency | Plasmablastic lymphoma | Chronic lymphocytic leukemia/small lymphocytic lymphoma | Epstein-Barr virus | Classical Hodgkin lymphoma | DISEASE VARIANT | PATHOLOGY | RICHTERS TRANSFORMATION | Hodgkin Disease - virology | Hodgkin Disease - pathology | Humans | Male | Antineoplastic Agents - therapeutic use | Neoplasms, Multiple Primary | Plasma Cells - pathology | Herpesvirus 4, Human - isolation & purification | Fatal Outcome | Hodgkin Disease - drug therapy | Clone Cells | B-Lymphocytes - pathology | Lymphoma, Large-Cell, Immunoblastic - virology | Lymphoproliferative Disorders - virology | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Epstein-Barr Virus Infections - pathology | Cell Transformation, Neoplastic | Leukemia, Lymphocytic, Chronic, B-Cell - virology | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Lymphoproliferative Disorders - drug therapy | Aged | Immunocompromised Host | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Lymphoma, Large-Cell, Immunoblastic - pathology | Immunoglobulins | Oncology, Experimental | Research | Antineoplastic agents | Virus diseases | Antimitotic agents | Chemotherapy | Chronic lymphocytic leukemia | Lymphomas | Cross infection | Nosocomial infections | Cancer | Tomography | Radiation therapy | Kinases | Tumors
Journal Article
Journal of Glaucoma, ISSN 1057-0829, 02/2011, Volume 20, Issue 2, pp. 115 - 117
Journal Article
Blood, ISSN 1528-0020, 1997, Volume 89, Issue 8, pp. 2966 - 2974
CD56 expression has been reported previously in some non-Hodgkin's lymphoma (NHL) characterization. They principally involve the nasopharynx, are related to... 
K MA HEMATOLOGY | NATURAL-KILLER-CELLS | IN-VITRO | LARGE GRANULAR LYMPHOCYTES | NK CELLS | GENE-EXPRESSION | PHENOTYPE | LYMPHOCYTE-PROLIFERATIVE DISORDERS | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | EPSTEIN-BARR-VIRUS | P-GLYCOPROTEIN | Cyclophosphamide - administration & dosage | Femoral Neoplasms - drug therapy | Drug Resistance, Multiple | Femoral Neoplasms - pathology | Neoplastic Stem Cells - drug effects | Humans | Drug Resistance, Neoplasm | Male | Lymphoma, Large-Cell, Immunoblastic - therapy | Lymphoma, Non-Hodgkin - pathology | Cisplatin - administration & dosage | Pelvic Neoplasms - therapy | Bone Marrow Transplantation | Fatal Outcome | Pelvic Neoplasms - drug therapy | Vincristine - administration & dosage | Adult | Female | Idarubicin - administration & dosage | Antineoplastic Agents - pharmacology | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Pelvic Neoplasms - pathology | Prednisone - administration & dosage | Neoplasm Invasiveness | CD56 Antigen - analysis | Etoposide - administration & dosage | Immunophenotyping | Combined Modality Therapy | Cell Nucleus - ultrastructure | Cytarabine - administration & dosage | Herpesvirus 4, Human | ATP-Binding Cassette, Sub-Family B, Member 1 - analysis | CD3 Complex - analysis | Lymphoma, T-Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell - pathology | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Neoplasm Proteins - analysis | Quinine - administration & dosage | Killer Cells, Natural - drug effects | Lymphoma, Large-Cell, Immunoblastic - pathology | Methylprednisolone - administration & dosage
Journal Article